Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

$23.72
-0.42 (-1.74%)
(As of 05/28/2024 ET)
Today's Range
$23.68
$24.18
50-Day Range
$23.72
$26.07
52-Week Range
$16.63
$26.16
Volume
4.14 million shs
Average Volume
5.52 million shs
Market Capitalization
$16.11 billion
P/E Ratio
60.82
Dividend Yield
N/A
Price Target
$26.71

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
12.6% Upside
$26.71 Price Target
Short Interest
Healthy
2.75% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.27
Upright™ Environmental Score
News Sentiment
1.10mentions of Avantor in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
22.77%
From $1.01 to $1.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.38 out of 5 stars

Medical Sector

107th out of 931 stocks

Analytical Instruments Industry

5th out of 30 stocks

AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Avantor, Inc. (AVTR)
Beyond The Numbers: 10 Analysts Discuss Avantor Stock
Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript
Avantor, Inc Q1 Profit Decreases, but beats estimates
Avantor® Reports First Quarter 2024 Results
Avantor Q1 2024 Earnings Preview
Bank of America Securities Keeps Their Buy Rating on Avantor (AVTR)
RBC Capital Keeps Their Buy Rating on Avantor (AVTR)
9 Analysts Assess Avantor: What You Need To Know
See More Headlines

Company Calendar

Last Earnings
4/26/2024
Today
5/28/2024
Next Earnings (Estimated)
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.71
High Stock Price Target
$30.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+12.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
4.88%

Debt

Sales & Book Value

Annual Sales
$6.97 billion
Cash Flow
$1.65 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
670,436,000
Market Cap
$16.11 billion
Optionable
Optionable
Beta
1.36

AVTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price target for 2024?

16 Wall Street analysts have issued twelve-month price objectives for Avantor's stock. Their AVTR share price targets range from $22.00 to $30.00. On average, they predict the company's stock price to reach $26.71 in the next year. This suggests a possible upside of 12.6% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How have AVTR shares performed in 2024?

Avantor's stock was trading at $22.83 at the beginning of the year. Since then, AVTR shares have increased by 3.9% and is now trading at $23.72.
View the best growth stocks for 2024 here
.

Are investors shorting Avantor?

Avantor saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 18,690,000 shares, a decrease of 25.3% from the April 30th total of 25,010,000 shares. Based on an average trading volume of 4,410,000 shares, the days-to-cover ratio is currently 4.2 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, July 26th 2024.
View our AVTR earnings forecast
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) announced its earnings results on Friday, April, 26th. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.02. The firm earned $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. Avantor had a trailing twelve-month return on equity of 13.01% and a net margin of 3.79%. The firm's revenue was down 5.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.29 EPS.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.49%), Boston Partners (4.20%), Canada Pension Plan Investment Board (3.16%), Janus Henderson Group PLC (2.10%), Artemis Investment Management LLP (1.34%) and Bessemer Group Inc. (1.05%). Insiders that own company stock include Christophe Couturier, David D Petratis, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Michael Stubblefield, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AVTR) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners